Skip to main content

Table 3 Baseline characteristics of patients from the included studies

From: Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials

Study/Year Age (yrs) Male (%) Ht (%) Hc (%) Cs (%) Qa
T/D T/D T/D T/D T/D  
Lee 2007 [34] 60.9/61.2 64.8/63.6 54.8/55.2 30.0/28.4 37.6/37.2 B
Lee 2008 [5] 61.0/60.7 59.0/57.0 59.5/59.5 30.5/28.5 24.0/31.5 B
Yang 2011 [35] 63.5/63.5 62.3/62.3 55.8/55.8 37.7/37.7 28.6/28.6 B
Yang 2009 [36] 63.4/63.8 40.0/60.0 61.9/57.1 28.6/41.2 14.3/20.6 B
Capranzano 2012 [37] 60.4/60.4 60.2/60.2 91.2/91.2 97.0/97.0 37.1/37.1 B
Angiolillo 2008 [38] 64.0/64.0 60.0/60.0 96.0/96.0 92.0/92.0 24.0/24.0 B
Angiolillo 2011 [39] 60.5/60.5 63.0/63.0 95.0/95.0 100.0/100.0 28.0/28.0 B
Ha 2013 [40] 64.9/62.3 67.7/76.1 71.4/76.1 33.3/42.5 23.8/23.8 B
Lee 2011 [33] 60.9/62.1 70.0/71.5 58.4/64.7 42.4/45.0 30.4/30.1 B
Han 2009 [6] 59.6/60.2 73.8/72.9 57.9/56.1 45.5/45.4 B
  1. Abbreviations:NM not mentioned, Ht hypertension, Hc hypercholesterolemia; Cs current smoker, T triple therapy, D dual therapy
  2. aQuality scale: A:true randomization and allocation concealed; B:process of randomization not given and concealment of allocation unclear